In Vitro and Cellular Probes to Study PARP Enzyme Target Engagement
- PMID: 32679093
- DOI: 10.1016/j.chembiol.2020.06.009
In Vitro and Cellular Probes to Study PARP Enzyme Target Engagement
Abstract
Poly(ADP-ribose) polymerase (PARP) enzymes use nicotinamide adenine dinucleotide (NAD+) to modify up to seven different amino acids with a single mono(ADP-ribose) unit (MARylation deposited by PARP monoenzymes) or branched poly(ADP-ribose) polymers (PARylation deposited by PARP polyenzymes). To enable the development of tool compounds for PARP monoenzymes and polyenzymes, we have developed active site probes for use in in vitro and cellular biophysical assays to characterize active site-directed inhibitors that compete for NAD+ binding. These assays are agnostic of the protein substrate for each PARP, overcoming a general lack of knowledge around the substrates for these enzymes. The in vitro assays use less enzyme than previously described activity assays, enabling discrimination of inhibitor potencies in the single-digit nanomolar range, and the cell-based assays can differentiate compounds with sub-nanomolar potencies and measure inhibitor residence time in live cells.
Keywords: NanoBRET; PARP7; TIPARP; bioluminescence resonance energy transfer (BRET); cellular biophysics; mono(ADP-ribosylation) (MARylation); nicotinamide adenine dinucleotide (NAD(+)); poly(ADP-ribose) polymerase (PARP); probe displacement; time-resolved fluorescence energy transfer (TR-FRET).
Copyright © 2020 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of Interests All authors are employees and shareholders of Ribon Therapeutics and a patent on this work has been granted (WO/2019/212946).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
